Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-16 8:52 pm Unchanged | 2025-10-14 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 6,485,420 11.500% | 0 (Unchanged) | Filing History |
| 2025-10-14 09:24 am Purchase | 2025-10-06 | 13G | Travere Therapeutics, Inc. TVTX | Perceptive Advisors LLC | 4,895,615 5.500% | 3,050,060 (+165.27%) | Filing History |
| 2025-10-10 12:50 pm Purchase | 2025-10-03 | 13G | Alto Neuroscience, Inc. ANRO | Perceptive Advisors LLC | 1,989,393 7.300% | 1,989,393 (New Position) | Filing History |
| 2025-10-09 4:00 pm Purchase | 2025-10-02 | 13G | Palisade Bio, Inc. PALI | Perceptive Advisors LLC | 12,243,018 9.990% | 12,243,018 (New Position) | Filing History |
| 2025-09-11 4:02 pm Purchase | 2025-09-04 | 13G | KALA BIO, Inc. KALA | Perceptive Advisors LLC | 543,745 7.700% | 543,745 (New Position) | Filing History |
| 2025-08-21 4:00 pm Purchase | 2025-08-14 | 13G | CytomX Therapeutics, Inc. CTMX | Perceptive Advisors LLC | 9,680,185 5.900% | 7,103,142 (+275.63%) | Filing History |
| 2025-08-14 5:21 pm Purchase | 2025-08-12 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 255,750 15.550% | 599 (+0.23%) | Filing History |
| 2025-08-14 5:20 pm Sale | 2025-06-30 | 13G | OnKure Therapeutics, Inc. OKUR | Perceptive Advisors LLC | 0 0.000% | -1,004,439 (Position Closed) | Filing History |
| 2025-08-14 4:26 pm Sale | 2025-06-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 699,486 3.200% | -741,763 (-51.47%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 7,412,830 2.400% | -14,051,697 (-65.46%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 4,639,949 4.400% | -1,755,597 (-27.45%) | Filing History |
| 2025-08-14 4:23 pm Sale | 2025-06-30 | 13G | Anteris Technologies Global Corp. AVR | Perceptive Advisors LLC | 1,705,130 4.700% | -734,870 (-30.12%) | Filing History |
| 2025-08-14 4:23 pm Sale | 2025-06-30 | 13G | Evolus, Inc. EOLS | Perceptive Advisors LLC | 2,474,843 3.800% | -1,654,299 (-40.06%) | Filing History |
| 2025-08-14 4:21 pm Sale | 2025-06-30 | 13G | Aldeyra Therapeutics, Inc. ALDX | Perceptive Advisors LLC | 4,051,631 6.800% | -824,220 (-16.90%) | Filing History |
| 2025-08-14 4:20 pm Sale | 2025-06-30 | 13G | Arcellx, Inc. ACLX | Perceptive Advisors LLC | 2,478,000 4.500% | -448,478 (-15.32%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | Verona Pharma plc VRNA | Perceptive Advisors LLC | 5,507,591 6.400% | -1,058,342 (-16.12%) | Filing History |
| 2025-08-07 11:36 am Sale | 2025-03-31 | 13G | Beta Bionics, Inc. BBNX | Perceptive Advisors LLC | 1,593,608 3.680% | -610,232 (-27.69%) | Filing History |
| 2025-08-04 5:46 pm Purchase | 2025-07-30 | 13G | Celcuity Inc. CELC | Perceptive Advisors LLC | 2,670,597 6.550% | 1,037,389 (+63.52%) | Filing History |
| 2025-08-04 5:44 pm Sale | 2025-06-30 | 13G | Celcuity Inc. CELC | Perceptive Advisors LLC | 1,633,208 4.310% | -729,071 (-30.86%) | Filing History |
| 2025-07-22 09:58 am Purchase | 2025-07-15 | 13G | Praxis Precision Medicines, Inc. PRAX | Perceptive Advisors LLC | 1,362,503 6.690% | 381,609 (+38.90%) | Filing History |